
Opinion|Videos|October 23, 2024
Unmet Needs and Future Research
Key Takeaways
- Understanding disease pathophysiology is essential for developing personalized treatment strategies and improving patient outcomes in type 2 inflammatory diseases.
- Identifying biomarkers can enhance disease monitoring and predict treatment responses, facilitating more effective management.
Panelists discuss how unmet needs in type 2 inflammatory diseases require further research, including developing more personalized treatment approaches, identifying novel biomarkers for better disease phenotyping, improving long-term disease control strategies, and addressing the psychosocial impacts of chronic inflammatory conditions to enhance patients’ overall quality of life and outcomes.
Advertisement
Episodes in this series

- What unmet needs require further research to improve quality of life and outcomes for patients living with type 2 inflammatory diseases?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Physician Peer Influence Drives Uptake of Opportunistic Salpingectomy for Ovarian Cancer Prevention
2
CAR T-Cell Therapy Holds Potential in SCLC, but Significant Barriers Remain
3
Value-Based Care Interventions and Management of CKD Progression
4
Defining the Role of Rilzabrutinib in ITP Management
5